A Glycoprotein Mutation That Emerged during the 2013–2016 Ebola Virus Epidemic Alters Proteolysis and Accelerates Membrane Fusion | mBio

DOI: 10.1128/mBio.03616-20

Article Information

DOI

https://doi.org/10.1128/mBio.03616-20

PubMed

Published By

American Society for Microbiology

History

Received December 21, 2020
Accepted January 4, 2021
Published online February 16, 2021.

Copyright & Usage

Copyright © 2021 Fels et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

Editors and / or Reviewers

Stacy M. Horner, Editor, Duke University Medical Center

Author Information

J. Maximilian Fels^a,
Robert H. Bortz III^a,
Tanwee Alkutkar^a *,
Eva Mittler^a,
Rohit K. Jangra^a,
Jennifer S. Spence^a,
Kartik Chandran^a

^aDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA

Address correspondence to Jennifer S. Spence, jspence008{at}gmail.com, or Kartik Chandran, kartik.chandran{at}einsteinmed.org.
↵* Present address: Tanwee Alkutkar, Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
Citation Fels JM, Bortz RH, III, Alkutkar T, Mittler E, Jangra RK, Spence JS, Chandran K. 2021. A glycoprotein mutation that emerged during the 2013–2016 Ebola virus epidemic alters proteolysis and accelerates membrane fusion. mBio 12:e03616-20. https://doi.org/10.1128/mBio.03616-20.

Article usage

Print

KEYWORDS

variant surface glycoprotein

Related Articles

Cited By...